Despite a 7.1% revenue increase and improved EBITDA margin, the company faces challenges like wage inflation, increased operating costs, and a widening net loss. The lack of a shareholder return plan and unclear management responses in the Q&A add to investor concerns. The absence of new partnerships or significant positive catalysts, combined with financial pressures and uncertainties in reimbursement, suggest a negative sentiment, likely leading to a stock price decline of -2% to -8% over the next two weeks.